Project documents | Tezacaftor and ivacaftor combination therapy for treating cystic fibrosis with the F508del mutation [ID1303] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 262 KB)

Published:

29 May 2018
NICE's response to comments on the draft scope and provisional matrix (PDF 531 KB)

Published:

29 May 2018
Final matrix (PDF 252 KB)

Published:

29 May 2018
Equality impact assessment (Scoping) (PDF 124 KB)

Published:

27 March 2019

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 348 KB)

Published:

30 November 2017
Draft matrix pre referral (PDF 252 KB)

Published:

30 November 2017